Steward Partners Investment Advisory, LLC Mirum Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.6 Billion
- Q3 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 8,664 shares of MIRM stock, worth $359,642. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,664
Previous 35,850
75.83%
Holding current value
$359,642
Previous $1.23 Million
72.49%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$273 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$186 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$143 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$134 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$128 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.53B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...